Please enable JavaScript to continue using this application.

Compare $COGT vs $ERAS | Chartloom

Compare

$COGT vs $ERAS

Cogent Biosciences Inc · Erasca Inc

COGT

Cogent Biosciences Inc

ERAS

Erasca Inc

Compare $COGT vs $ERAS

Comparing Cogent Biosciences Inc and Erasca Inc

COGTCogent Biosciences Inc

ERASErasca Inc

COGTCogent Biosciences Inc

Market cap

$5.30B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

24.59x

Rev growth (TTM)

—

YTD performance

-10.8%

52W performance

99.0%

FCF yield

-5.8%

ERASErasca Inc

Market cap

$5.49B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

346.5%

52W performance

559.7%

FCF yield

-1.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

COGT

ERAS

Detailed metrics comparison

COGT

Cogent Biosciences Inc

ERAS

Erasca Inc

Market Cap

COGT$5.30B

ERAS$5.49B

Enterprise Value

COGT$5.34B

ERAS$5.44B

Price

COGT$31.00

ERAS$16.03

P/E Ratio

COGTN/A

ERASN/A

P/S Ratio

COGT232.42x

ERAS0.00x

EV/Sales

COGT234.24x

ERAS0.00x

EV/EBITDA

COGT0.00x

ERAS0.00x

P/B Ratio

COGT10.11x

ERAS14.25x

P/FCF Ratio

COGTN/A

ERASN/A

EV/FCF

COGT-17.27x

ERAS-55.50x

PEG Ratio

COGTN/A

ERASN/A

Forward P/E (NTM)

COGTN/A

ERASN/A

Forward P/S (NTM)

COGT24.59x

ERASN/A

Revenue (TTM)

COGT$0

ERAS$0

Revenue Growth (YoY)

COGTN/A

ERASN/A

Forward Rev Growth

COGT2636.5%

ERAS959.7%

Gross Margin (TTM)

COGT0.0%

ERAS0.0%

Operating Margin (TTM)

COGT0.0%

ERAS0.0%

EBITDA Margin (TTM)

COGT0.0%

ERAS0.0%

Net Margin (TTM)

COGT0.0%

ERAS0.0%

FCF Margin (TTM)

COGTN/A

ERASN/A

Net Income (TTM)

COGT$-332M

ERAS$-287M

FCF (TTM)

COGT$-309M

ERAS$-98M

EPS (TTM)

COGT-$1.94

ERAS-$0.92

ROE (TTM)

COGT-7257.0%

ERAS-8043.0%

ROA (TTM)

COGT-4865.0%

ERAS-6708.0%

ROIC (TTM)

COGT-5402.0%

ERAS-8043.0%

Cash

COGT$181M

ERAS$43M

Debt

COGT$223M

ERAS$0

Net Cash/Debt

COGT$-42M

ERAS$43M

Current Ratio (TTM)

COGT13.57x

ERAS8.29x

Quick Ratio (TTM)

COGT13.36x

ERAS8.08x

Debt/Equity (TTM)

COGT0.42x

ERAS0.00x

Debt/Assets (TTM)

COGT0.0%

ERAS0.0%

Interest Coverage (TTM)

COGTN/A

ERASN/A

Net Debt/EBITDA (TTM)

COGT0.00x

ERAS0.00x

Beta

COGT0.34

ERAS0.67

52W Performance

COGT99.0%

ERAS559.7%

YTD Performance

COGT-10.8%

ERAS346.5%

% from 52W High

COGT-29.1%

ERAS-34.0%

% from 52W Low

COGT125.0%

ERAS661.5%

Asset Turnover (TTM)

COGT0.36x

ERAS0.00x

FCF Yield (TTM)

COGT-5.8%

ERAS-1.8%

Earnings Yield (TTM)

COGT-6.3%

ERAS-5.2%

Dividend Yield (TTM)

COGTN/A

ERASN/A

Rule of 40

COGT0.0

ERAS0.0

EV/GP/RG

COGTN/A

ERASN/A

Ticker research

View COGT research View ERAS research

Metric	COGT Cogent Biosciences Inc	ERAS Erasca Inc
Market & Valuation
Market Cap	$5.30B	$5.49B
Enterprise Value	$5.34B	$5.44B
Price	$31.00	$16.03
P/E Ratio	N/A	N/A
P/S Ratio	232.42x	0.00x
EV/Sales	234.24x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	10.11x	14.25x
P/FCF Ratio	N/A	N/A
EV/FCF	-17.27x	-55.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	24.59x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	2636.5%	959.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-332M	$-287M
FCF (TTM)	$-309M	$-98M
EPS (TTM)	-$1.94	-$0.92
ROE (TTM)	-7257.0%	-8043.0%
ROA (TTM)	-4865.0%	-6708.0%
ROIC (TTM)	-5402.0%	-8043.0%
Financial Health
Cash	$181M	$43M
Debt	$223M	$0
Net Cash/Debt	$-42M	$43M
Current Ratio (TTM)	13.57x	8.29x
Quick Ratio (TTM)	13.36x	8.08x
Debt/Equity (TTM)	0.42x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.34	0.67
52W Performance	99.0%	559.7%
YTD Performance	-10.8%	346.5%
% from 52W High	-29.1%	-34.0%
% from 52W Low	125.0%	661.5%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.00x
FCF Yield (TTM)	-5.8%	-1.8%
Earnings Yield (TTM)	-6.3%	-5.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View COGT research	View ERAS research

Valuation

P/S Ratio

ERAS

0.00x

COGT

232.42x

EV/FCF

ERAS

-55.50x

COGT

-17.27x

Growth & revenue

Forward Revenue Growth

COGT

2636.5%

ERAS

959.7%

Profitability & performance

Gross Margin

COGT

0.0%

ERAS

0.0%

ROE

COGT

-7257.0%

ERAS

-8043.0%

FCF Yield %

ERAS

-1.8%

COGT

-5.8%

52-Week Performance

ERAS

559.7%

COGT

99.0%

Detailed metrics comparison

COGT

Cogent Biosciences Inc

ERAS

Erasca Inc

Market Cap

COGT$5.30B

ERAS$5.49B

Enterprise Value

COGT$5.34B

ERAS$5.44B

Price

COGT$31.00

ERAS$16.03

P/E Ratio

COGTN/A

ERASN/A

P/S Ratio

COGT232.42x

ERAS0.00x

EV/Sales

COGT234.24x

ERAS0.00x

EV/EBITDA

COGT0.00x

ERAS0.00x

P/B Ratio

COGT10.11x

ERAS14.25x

P/FCF Ratio

COGTN/A

ERASN/A

EV/FCF

COGT-17.27x

ERAS-55.50x

PEG Ratio

COGTN/A

ERASN/A

Forward P/E (NTM)

COGTN/A

ERASN/A

Forward P/S (NTM)

COGT24.59x

ERASN/A

Revenue (TTM)

COGT$0

ERAS$0

Revenue Growth (YoY)

COGTN/A

ERASN/A

Forward Rev Growth

COGT2636.5%

ERAS959.7%

Gross Margin (TTM)

COGT0.0%

ERAS0.0%

Operating Margin (TTM)

COGT0.0%

ERAS0.0%

EBITDA Margin (TTM)

COGT0.0%

ERAS0.0%

Net Margin (TTM)

COGT0.0%

ERAS0.0%

FCF Margin (TTM)

COGTN/A

ERASN/A

Net Income (TTM)

COGT$-332M

ERAS$-287M

FCF (TTM)

COGT$-309M

ERAS$-98M

EPS (TTM)

COGT-$1.94

ERAS-$0.92

ROE (TTM)

COGT-7257.0%

ERAS-8043.0%

ROA (TTM)

COGT-4865.0%

ERAS-6708.0%

ROIC (TTM)

COGT-5402.0%

ERAS-8043.0%

Cash

COGT$181M

ERAS$43M

Debt

COGT$223M

ERAS$0

Net Cash/Debt

COGT$-42M

ERAS$43M

Current Ratio (TTM)

COGT13.57x

ERAS8.29x

Quick Ratio (TTM)

COGT13.36x

ERAS8.08x

Debt/Equity (TTM)

COGT0.42x

ERAS0.00x

Debt/Assets (TTM)

COGT0.0%

ERAS0.0%

Interest Coverage (TTM)

COGTN/A

ERASN/A

Net Debt/EBITDA (TTM)

COGT0.00x

ERAS0.00x

Beta

COGT0.34

ERAS0.67

52W Performance

COGT99.0%

ERAS559.7%

YTD Performance

COGT-10.8%

ERAS346.5%

% from 52W High

COGT-29.1%

ERAS-34.0%

% from 52W Low

COGT125.0%

ERAS661.5%

Asset Turnover (TTM)

COGT0.36x

ERAS0.00x

FCF Yield (TTM)

COGT-5.8%

ERAS-1.8%

Earnings Yield (TTM)

COGT-6.3%

ERAS-5.2%

Dividend Yield (TTM)

COGTN/A

ERASN/A

Rule of 40

COGT0.0

ERAS0.0

EV/GP/RG

COGTN/A

ERASN/A

Ticker research

View COGT research View ERAS research

Metric	COGT Cogent Biosciences Inc	ERAS Erasca Inc
Market & Valuation
Market Cap	$5.30B	$5.49B
Enterprise Value	$5.34B	$5.44B
Price	$31.00	$16.03
P/E Ratio	N/A	N/A
P/S Ratio	232.42x	0.00x
EV/Sales	234.24x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	10.11x	14.25x
P/FCF Ratio	N/A	N/A
EV/FCF	-17.27x	-55.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	24.59x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	2636.5%	959.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-332M	$-287M
FCF (TTM)	$-309M	$-98M
EPS (TTM)	-$1.94	-$0.92
ROE (TTM)	-7257.0%	-8043.0%
ROA (TTM)	-4865.0%	-6708.0%
ROIC (TTM)	-5402.0%	-8043.0%
Financial Health
Cash	$181M	$43M
Debt	$223M	$0
Net Cash/Debt	$-42M	$43M
Current Ratio (TTM)	13.57x	8.29x
Quick Ratio (TTM)	13.36x	8.08x
Debt/Equity (TTM)	0.42x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.34	0.67
52W Performance	99.0%	559.7%
YTD Performance	-10.8%	346.5%
% from 52W High	-29.1%	-34.0%
% from 52W Low	125.0%	661.5%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.00x
FCF Yield (TTM)	-5.8%	-1.8%
Earnings Yield (TTM)	-6.3%	-5.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View COGT research	View ERAS research